Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2018
  • 2016
  • 2015
  • 2014
  • 2011

Author

  • Keith Lindor

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

12 Scopus citations

Emerging therapeutic targets for primary sclerosing cholangitis

Kalani, A., Tabibian, J. H. & Lindor, K., Jul 3 2018, In : Expert Opinion on Orphan Drugs. 6, 7, p. 393-401 9 p.

Research output: Contribution to journalReview article

Erratum: Primary biliary cirrhosis (Lancet (2015) 386 (1565-1575))

Carey, E. J., Ali, A. H. & Lindor, K., 2015, In : The Lancet. 386, 10003, p. 1536 1 p.

Research output: Contribution to journalArticle

Eyewitnesses to history and participants as well

Lindor, K. D., Dec 1 2011, In : Hepatology. 54, 6, 1 p.

Research output: Contribution to journalComment/debate

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

12 Scopus citations

Farnesoid X receptor agonists for primary biliary cirrhosis

Lindor, K. D., May 1 2011, In : Current Opinion in Gastroenterology. 27, 3, p. 285-288 4 p.

Research output: Contribution to journalArticle

38 Scopus citations

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

Foreword

Lindor, K., Jan 1 2014, In : Unknown Journal. p. vii-viii

Research output: Contribution to journalArticle

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Reed, D. A., Enders, F., Lindor, R., McClees, M. & Lindor, K. D., Jan 2011, In : Academic Medicine. 86, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

137 Scopus citations

Hepatic fibrosis and the renin-angiotensin system

Abbas, G., Silveira, M. G. & Lindor, K. D., Nov 1 2011, In : American Journal of Therapeutics. 18, 6, p. e202-e208

Research output: Contribution to journalArticle

21 Scopus citations

Hepatocellular carcinoma: Low risk of HCC in patients who have PSC and cirrhosis

Gossard, A. A. & Lindor, K., May 2014, In : Nature Reviews Gastroenterology and Hepatology. 11, 5, p. 276-277 2 p.

Research output: Contribution to journalArticle

6 Scopus citations

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Imam, M. H., Sinakos, E., Gossard, A. A., Kowdley, K. V., Luketic, V. A. C., Edwyn Harrison, M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Decook, A. C., Enders, F. & Lindor, K. D., Nov 2011, In : Alimentary Pharmacology and Therapeutics. 34, 10, p. 1185-1192 8 p.

Research output: Contribution to journalArticle

61 Scopus citations

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A. C., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J. & Lindor, K. D., Sep 2011, In : American Journal of Gastroenterology. 106, 9, p. 1638-1645 8 p.

Research output: Contribution to journalReview article

164 Scopus citations

Immunoglobulin G4-associated autoimmune cholangiopathy

Lindor, K. D., Apr 1 2011, In : Gastroenterology and Hepatology. 7, 4, p. 259-261 3 p.

Research output: Contribution to journalComment/debate

7 Scopus citations

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis

Cholankeril, G., Gonzalez, H. C., Satapathy, S. K., Gonzalez, S. A., Hu, M., Khan, M. A., Yoo, E. R., Li, A. A., Kim, D., Nair, S., Wong, R. J., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Lindor, K. & Ahmed, A., Jun 2018, In : Clinical Gastroenterology and Hepatology. 16, 6, p. 965-973.e2

Research output: Contribution to journalArticle

8 Scopus citations

Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

Fibrotic Liver Disease Consortium Investigators, Aug 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 8, p. 1342-1350.e1

Research output: Contribution to journalArticle

16 Scopus citations

In reply

Reed, D. A. & Lindor, K. D., Aug 2011, In : Academic Medicine. 86, 8, 1 p.

Research output: Contribution to journalLetter

1 Scopus citations

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Journal of Hepatology. 65, 4, p. 661-662 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

4 Scopus citations

Leader's portrait

Lindor, K. D., 2011, In : Clinics and Research in Hepatology and Gastroenterology. 35, 6-7, p. 423-425 3 p.

Research output: Contribution to journalEditorial

Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

Global PBC Study Group, Dec 1 2014, In : Gastroenterology. 147, 6, p. 1338-1349.e5

Research output: Contribution to journalArticle

175 Scopus citations

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A. & Lindor, K., Jun 2 2016, In : Scandinavian Journal of Gastroenterology. 51, 6, p. 745-752 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Dong, T. S., Kalani, A., Aby, E. S., Le, L., Luu, K., Hauer, M., Kamath, R., Lindor, K. & Tabibian, J. H., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1894-1901.e1

Research output: Contribution to journalArticle

5 Scopus citations

Magic wand and crystal ball for primary sclerosing cholangitis

Vuppalanchi, R. & Lindor, K., Apr 2014, In : Gastroenterology. 146, 4, p. 890-892 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

24 Scopus citations

Managing PBC: Expanding the Provider Comfort Zone

Chascsa, D. M. & Lindor, K., Jun 9 2018, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma

Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R. & Lindor, K. D., May 2011, In : Clinical Gastroenterology and Hepatology. 9, 5, p. 434-439.e1

Research output: Contribution to journalArticle

73 Scopus citations

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

on behalf of the GLOBAL PBC Study Group, May 2018, In : Hepatology. 67, 5, p. 1920-1930 11 p.

Research output: Contribution to journalArticle

15 Scopus citations

Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis

Imam, M. H., Eaton, J. E., Puckett, J. S., Loftus, E. V., Mathis, K. L., Gossard, A. A., Talwalkar, J. A. & Lindor, K., Oct 1 2014, In : Journal of Crohn's and Colitis. 8, 10, p. 1294-1299 6 p.

Research output: Contribution to journalArticle

15 Scopus citations

New treatment strategies for primary sclerosing cholangitis

Lindor, K. D., Jun 1 2011, In : Digestive Diseases. 29, 1, p. 113-116 4 p.

Research output: Contribution to journalArticle

14 Scopus citations

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

3 Scopus citations

Nonalcoholic fatty liver disease and the coronary artery disease

Treeprasertsuk, S., Lopez-Jimenez, F. & Lindor, K. D., Jan 1 2011, In : Digestive Diseases and Sciences. 56, 1, p. 35-45 11 p.

Research output: Contribution to journalReview article

44 Scopus citations

Novel therapeutic targets in primary biliary cirrhosis

Dyson, J. K., Hirschfield, G. M., Adams, D. H., Beuers, U., Mann, D. A., Lindor, K. & Jones, D. E. J., Mar 6 2015, In : Nature Reviews Gastroenterology and Hepatology. 12, 3, p. 147-158 12 p.

Research output: Contribution to journalReview article

66 Scopus citations

Novel treatments in primary sclerosing cholangitis

Ali, A. H. & Lindor, K., Nov 1 2016, In : Clinical Liver Disease. 8, 5, p. 132-135 4 p.

Research output: Contribution to journalReview article

1 Scopus citations

Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis

Silveira, M. G. & Lindor, K., Feb 1 2014, In : Expert Opinion on Pharmacotherapy. 15, 3, p. 365-372 8 p.

Research output: Contribution to journalReview article

30 Scopus citations

Obeticholic acid for the treatment of primary biliary cholangitis

Ali, A. H. & Lindor, K., Sep 1 2016, In : Expert Opinion on Pharmacotherapy. 17, 13, p. 1809-1815 7 p.

Research output: Contribution to journalReview article

23 Scopus citations

Oral vancomycin therapy in a child with primary sclerosing cholangitis and severe ulcerative colitis

Buness, C., Lindor, K. & Miloh, T., 2016, In : Pediatric Gastroenterology, Hepatology and Nutrition. 19, 3, p. 210-213 4 p.

Research output: Contribution to journalArticle

7 Scopus citations

Orphan drugs in development for primary biliary cirrhosis: Challenges and progress

Ali, A. H., Byrne, T. J. & Lindor, K., 2015, In : Orphan Drugs: Research and Reviews. 5, p. 83-97 15 p.

Research output: Contribution to journalReview article

Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis

Treeprasertsuk, S., Silveira, M. G., Petz, J. L. & Lindor, K. D., Sep 1 2011, In : American Journal of Therapeutics. 18, 5, p. 375-381 7 p.

Research output: Contribution to journalArticle

13 Scopus citations

Patients With Typical Laboratory Features of Autoimmune Hepatitis Rarely Need a Liver Biopsy for Diagnosis

Björnsson, E., Talwalkar, J., Treeprasertsuk, S., Neuhauser, M. & Lindor, K., Jan 1 2011, In : Clinical Gastroenterology and Hepatology. 9, 1, p. 57-63 7 p.

Research output: Contribution to journalArticle

29 Scopus citations

Pilot study: Fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

Levy, C., Peter, J. A., Nelson, D. R., Keach, J., Petz, J., Cabrera, R., Clark, V., Firpi, R. J., Morelli, G., Soldevila-Pico, C. & Lindor, K., Jan 1 2011, In : Alimentary Pharmacology and Therapeutics. 33, 2, p. 235-242 8 p.

Research output: Contribution to journalArticle

98 Scopus citations

Pregnancy in primary sclerosing cholangitis

Gossard, A. & Lindor, K., Aug 1 2011, In : Gut. 60, 8, p. 1027-1028 2 p.

Research output: Contribution to journalComment/debate

2 Scopus citations

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, K., Bowlus, C. L., Boyer, J., Levy, C. & Mayo, M., Jan 2019, In : Hepatology. 69, 1, p. 394-419 26 p.

Research output: Contribution to journalArticle

78 Scopus citations

Primary biliary cirrhosis: Safety and benefits of established and emerging therapies

Tabibian, J. H. & Lindor, K., Sep 2 2015, In : Expert Opinion on Drug Safety. 14, 9, p. 1435-1444 10 p.

Research output: Contribution to journalArticle

6 Scopus citations

Primary biliary cirrhosis

Carey, E. J., Ali, A. H. & Lindor, K., Oct 17 2015, In : The Lancet. 386, 10003, p. 1565-1575 11 p.

Research output: Contribution to journalArticle

220 Scopus citations

Primary biliary cirrhosis in adults

Momah, N. & Lindor, K., May 2014, In : Expert Review of Gastroenterology and Hepatology. 8, 4, p. 427-433 7 p.

Research output: Contribution to journalReview article

19 Scopus citations

Primary sclerosing cholangitis, part 1: Epidemiology, etiopathogenesis, clinical features, and treatment

Tabibian, J. H., Ali, A. H. & Lindor, K., May 1 2018, In : Gastroenterology and Hepatology. 14, 5, p. 293-304 12 p.

Research output: Contribution to journalArticle

7 Scopus citations

Primary sclerosing cholangitis, part 2: Cancer risk, prevention, and surveillance

Tabibian, J. H., Ali, A. H. & Lindor, K., Jul 1 2018, In : Gastroenterology and Hepatology. 14, 7, p. 427-432 6 p.

Research output: Contribution to journalArticle

6 Scopus citations

Primary sclerosing cholangitis and the microbiota: Current knowledge and perspectives on etiopathogenesis and emerging therapies

Tabibian, J. H., O'Hara, S. P. & Lindor, K., Aug 2014, In : Scandinavian Journal of Gastroenterology. 49, 8, p. 901-908 8 p.

Research output: Contribution to journalReview article

52 Scopus citations

Primary sclerosing cholangitis associated with elevated immunoglobulinG4: Clinical characteristics and response to therapy

Björnsson, E., Chari, S., Silveira, M., Gossard, A., Takahashi, N., Smyrk, T. & Lindor, K., May 1 2011, In : American Journal of Therapeutics. 18, 3, p. 198-205 8 p.

Research output: Contribution to journalArticle

91 Scopus citations